Skip to search formSkip to main contentSkip to account menu

Anti-PD-L1 Monoclonal Antibody MDX-1105

Known as: MDX-1105 
A fully human monoclonal antibody directed against programmed cell death-1 ligand 1 (PD-L1) with immune checkpoint inhibitory and potential… 
National Institutes of Health

Related topics

Related topics

1 relation
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
PD-1 and cancer: molecular mechanisms and polymorphisms
The programmed cell death protein 1 (PD-1) is expressed by activated T cells that act as an immunoregulatory molecule, and are… 
2015
2015
Targeting the immune system in head and neck cancer.
DOI:10.1097/CCO.0000000000000189 To evade immune destruction is considered one of the hallmarks of cancer [1]. This escape does… 
2011
2011
Abstract IA7: Blockade of immunologic checkpoints in cancer therapy: The B7-H1/PD-1 pathway
Malignant cells display altered surface molecular signatures distinguishing them quantitatively and qualitatively from their… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)